BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23208715)

  • 1. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
    Pang Y; Lu J; Wang Y; Song Y; Wang S; Zhao Y
    Antimicrob Agents Chemother; 2013 Feb; 57(2):893-900. PubMed ID: 23208715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates.
    Li G; Zhang J; Guo Q; Wei J; Jiang Y; Zhao X; Zhao LL; Liu Z; Lu J; Wan K
    J Antibiot (Tokyo); 2015 Jul; 68(7):431-5. PubMed ID: 25690361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
    Jamieson FB; Guthrie JL; Neemuchwala A; Lastovetska O; Melano RG; Mehaffy C
    J Clin Microbiol; 2014 Jun; 52(6):2157-62. PubMed ID: 24740074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
    Choi GE; Lee SM; Yi J; Hwang SH; Kim HH; Lee EY; Cho EH; Kim JH; Kim HJ; Chang CL
    J Clin Microbiol; 2010 Nov; 48(11):3893-8. PubMed ID: 20844231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X
    J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
    Ozturk CE; Sanic A; Kaya D; Ceyhan I
    Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Level Rifampin Resistance and
    Shea J; Halse TA; Kohlerschmidt D; Lapierre P; Modestil HA; Kearns CH; Dworkin FF; Rakeman JL; Escuyer V; Musser KA
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 32999007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.
    Narang A; Garima K; Porwal S; Bhandekar A; Shrivastava K; Giri A; Sharma NK; Bose M; Varma-Basil M
    PLoS One; 2019; 14(9):e0223163. PubMed ID: 31557231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China.
    Wang YC; Zhu RY; Xu YY; Zhao MQ; Liu YH; Li B; Chen JD
    Jpn J Infect Dis; 2009 Jul; 62(4):270-4. PubMed ID: 19628903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant
    He G; Zheng Q; Wu J; Wu L; Geng Z; Jiang G; Huang H; Jiang X; Yu X
    Microbiol Spectr; 2024 Jun; 12(6):e0385923. PubMed ID: 38738892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.
    Minh NN; Van Bac N; Son NT; Lien VT; Ha CH; Cuong NH; Mai CT; Le TH
    J Clin Microbiol; 2012 Mar; 50(3):598-601. PubMed ID: 22170905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.